Business News

Natco challenges Novartis’s second patent for cancer drug ribociclib in Delhi High Court

Wednesday, August 5, 2026 - 23:19
0 1
Natco challenges Novartis’s second patent for cancer drug ribociclib in Delhi High Court
Natco claims the new patent unlawfully extends Novartis’s market monopoly over the breast cancer medicine past 2027; Delhi High Court issues notices to all parties.

Read More
Previous Article

After FSSAI's Old Monk action, could Minty Jamun and Mango Chilli Vodka face ...

Next Article

River Mobility raises $120 mn to scale manufacturing, expand retail reach

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0

Related Posts

Government asks industry bodies to tighten certification checks, conduct regular cybersecurity audits

Government asks industry bodies to tighten certifica...

Saturday, October 24, 2026
0
1
TN CM Vijay’s government to distribute 62 lakh cake pieces to school students on Children’s Day

TN CM Vijay’s government to distribute 62 lakh cake ...

Saturday, October 24, 2026
0
1
Mana Estates projects ₹3,000 crore sales this fiscal, 10 mn sq ft pipeline in two years

Mana Estates projects ₹3,000 crore sales this fiscal...

Saturday, October 24, 2026
0
1
PGTI, Essar partner to launch new annual tournament on India’s professional golf calendar

PGTI, Essar partner to launch new annual tournament ...

Saturday, October 24, 2026
0
1
Stay vigilant, adopt long-term vision: Defence Minister Rajnath Singh tells Army leadership

Stay vigilant, adopt long-term vision: Defence Minis...

Saturday, October 24, 2026
0
1
Chennai airport ATF tax cut to 16% from 29%; rate slashed to 1% for other TN airports

Chennai airport ATF tax cut to 16% from 29%; rate sl...

Saturday, October 24, 2026
0
0

Comments (0)

User